Insulet Corporation

NASDAQ:PODD

Medical - Devices

Healthcare
$139.98 -2.82%

-$4.17 today

Market cap
$9.71B
Beta
1.13
P/E (TTM)
33.2
EPS (TTM)
$4.33
52W Low $140.63High $354.88

Volume 2.09M

Average 1.32M

PODD Net Change in Cash

Combined operating, investing, financing, and currency effects on the cash balance during the period.

Insulet CorporationNASDAQ: PODD

Net Change in Cash · Q2 FY2026 · quarter ended Jun 2026

Net change in cash turns positive

Q2 FY2026 net change in cash was $54.5M, compared with -$161.5M a year earlier. Trailing-twelve-month net change in cash was -$586.7M. Over 3 fiscal years it compounded at +26.7% a year.

Context

  • Net change in cash amounted to 8.8% of revenue in FY2025, down 3.3 pp from a year earlier.
  • Net change in cash increased in 2 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly net change in cash holds near $54.5M or moves back toward the trailing-twelve-month quarterly average of -$146.68M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$54.5M+123.1% QoQ
Last fiscal yearDec 2025
-$237.3M-195.2% YoY
LTMJun 2026
-$586.7M-295.2% YoY
Net Change in Cash past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+133.7%——
1 year-195.2%——
3-year CAGR+26.7%——
5-year CAGR——
10-year CAGR——

Net Change in Cash history

USD · from the cash flow

Latest · FY2025
(237.3M) USD
Year-over-year change
-195.2%

Net Change in Cash vs competitors

How PODD compares with its peers on the latest reported figures

  • PODD's LTM Jun 2026 net change in cash of $586.7M is the largest of the 5 companies compared; the peer median is $10.97M.
  • Its year-over-year change of -295.2% is the lowest of 5, against a peer median of -103.0%.
  • Net change in cash amounts to 19.2% of revenue for PODD, versus a peer median of 11.7%.
PODD Competitors Peer median
Net Change in Cash for PODD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PODDInsulet CorporationLTM Jun 2026$586.7M -295.2%+26.7%19.2%
TNDMTandem Diabetes Care, Inc.LTM Mar 2026$125.75M +2426.6%-40.4%12.2%
DXCMDexCom, Inc.LTM Jun 2026$55.1M -124.9%—1.1%
BBNXBeta Bionics, Inc.LTM Mar 2026$12.25M -136.7%—11.1%
SENSSenseonics Holdings, Inc.LTM Mar 2026$9.7M -81.1%—23.8%
Peer median (excluding PODD) $10.97M-103.0%-40.4%11.7%

Competitors are the stored peer set for PODD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income16.8M4.6M206.3M418.3M247.1M
Depreciation & Amortization57.4M63.2M72.8M80.8M90.4M
Deferred Income Tax0(1M)500K(136.9M)62.2M
Stock-Based Compensation34.4M40.9M48.3M69.3M62.7M
Change in Working Capital(263.6M)(2.5M)(190.6M)(17M)(23.1M)
Accounts Receivables(71.3M)(51.8M)(154.2M)(10.4M)(140.2M)
Inventory(154.4M)(49.1M)(53.6M)(32.4M)(10.6M)
Accounts Payables(15.6M)(2.4M)(11M)2.2M49.2M
Other Working Capital(22.3M)100.8M28.2M23.6M78.5M
Other Non-Cash Items86.9M13.8M8.4M15.8M130M
Operating Cash Flow(68.1M)119M145.7M430.3M569.3M
Capital Expenditures(122.7M)(157.3M)(75.6M)(124.9M)(191.6M)
Acquisitions (Net)0(26M)(3M)00
Purchases of Investments0(7.8M)(7.2M)(12.2M)0
Sales of Investments40M0000
Other Investing Activities0000(31.1M)
Investing Cash Flow(82.7M)(191.1M)(119.4M)(146.2M)(222.7M)
Debt Repayment49.4M(39.8M)(27M)(40.6M)(708.1M)
Common Stock Issued23.5M16.3M26.9M20.1M33.9M
Common Stock Repurchased0000(59.6M)
Dividends Paid00000
Other Financing Activities(32.2M)(16.8M)(13.5M)(7.6M)138.5M
Financing Cash Flow40.7M(40.3M)(13.6M)(28.1M)(595.3M)
Effect of Forex Changes(5.5M)(4.3M)1.8M(6.8M)11.5M
Net Change in Cash(115.6M)(116.7M)14.5M249.2M(237.3M)
Free Cash Flow(190.8M)(38.3M)70.1M305.4M377.7M

Insulet Corporation

NASDAQ:PODD

Intrinsic Alpha fair value

Locked

Current Price

$139.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.